CORRESPONDENCE
In their Perspective article (Common misconceptions about vitamin D-implications for clinicians. Nat Rev. Endocrinol. doi:10.1038 Endocrinol. doi:10. /nrendo.2013 , 1 Rosen and Taylor have provided a primer on the state of vitamin D research. However, the analyses presented of the current literature are not balanced. The conclusions of the authors largely reflect those of the 2011 Institute of Medicine (IOM) report, 2 which immediately created a controversy, leading to published rebuttals. 3 The IOM report was controversial in part because of its very conservative recommendations for dietary intakes, its conclusions of insufficient evidence for any role of vitamin D in nonbone health, and the way it presented evidence for the potential harm associated with ci rculating 25-hydroxyvitamin D levels.
Notably, considerable debate surrounds potential roles of vitamin D in nonbone indications including cancer prevention and control of immune system function. The authors conclude that "effects of vitamin D on nonbone disorders is currently best described as consisting of hypotheses of emerging interest".
1 They also claim that vitamin D supplementation has not been shown to prevent infections. In fact, several randomized placebo-controlled trials have been published providing evidence for vitamin D supplementation of deficient populations in preventing a variety of infections. In addition to the (highly cited) results of a trial published in 2010 concluding that Vitamin D and human health: more than just bone John H. White vitamin D supplementation reduced the risk of seasonal influenza infections in a paedi atric population, 4 recent studies have provided evidence for a beneficial role of vitamin D supplementation of populations at risk for upper respiratory tract or ear infections, either because of severe vitamin D deficiency or a history of recurrent infections. 5, 6 By contrast, one study that produced a nega tive result involved a healthy population with baseline 25-hydroxy vitamin D levels of 73 nmol/l. 7 The authors also discuss the emerging evidence for a U-shaped curve of risk associated with 25-hydroxyvitamin D levels and focus largely on the potential risks associated with excessive vitamin D intake, an area that should not be ignored. They cite a recent review 8 suggesting that there may be an increase in prevalence of certain cancers associated with high serum 25-hydroxyvitamin D levels (>75 nmol/l). However, U-shaped curves have two sides, and the IOM recommends that the vitamin D needs of ~50% of the population can be met with 25-hydroxyvitamin D levels of 30-40 nmol/l, whereas those of most of the remainder require 40-50 nmol/l. If followed, these recom mendations would place the entire population solidly within the left-hand side of the U-shaped curve of cancer risk. It can there fore be argued that one of the misconceptions arising from conservative estimates of recommended vitamin D intake in the IOM report is that less vitamin D does no harm.
